BioSpace News Archive

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) (“FSD Pharma” or the “Company”) today announced the sale of 5.0 million common shares of Pharmadrug Inc. (CSE:BUZZ) (formerly Aura Health) in a privately negotiated transaction at C$0.08 per share for cash proceeds of C$400,000. Under the terms of the sale, the buyer has the option through June 26, 2020 to purchase

Ortek Therapeutics, Inc. announced the official US commercial launch of the Ortek-ECD™, a breakthrough electronic early cavity detection system that has been cleared by the FDA for professional use only.

Devonian Health Group Inc., a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced the nomination of Dr Andre P. Boulet, PhD, as representative of Canada within the American Botanical Drug Association.

AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2028 (the “Notes”), subject to market and other conditions. The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Teleflex’s existing and future wholly-owned domestic subsidiaries that is a guarantor or other obligor und

Companion Medical, the producers of InPen, the only FDA-cleared reusable smart insulin pen system, announced that co-founder and CEO, Sean Saint, has been named as one of the Top 50 Healthcare Technology CEOs of 2020 by The Healthcare Technology Report.

Primary endpoint met with confirmation of drug’s safety and tolerability Strong effects on secondary endpoints on activity markers and disease progression Improvement or stabilisation across different measures of motor function & strength Activity on the targeted CD49d immune cells consistent with drug’s proposed mechanism of action New MRI data suggests stabilisation of percentage of fat in muscles and preservatio

The fast-reacting kit allows users to test surfaces on-site or remotely for Coronavirus in just over an hour, providing validation of companies’ disinfection procedures to create safe conditions and peace of mind for employees and customers

American BriVision Corporation, a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS and ophthalmology, said its recently announced private placement of 444,445 common shares has been expanded to 890,000 common shares.

After years of continued success in their field, Revelox is bringing their signature product line to the Efficient Collaborative Retail Marketing conference for ECRM’s historic virtual expo, May 18th through May 21st.